IQVIA HOLDINGS INC. Revenues
IQVIA HOLDINGS INC. (IQV) reported Revenues of $9.74 billion for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-16.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2018-02-16
- IQVIA HOLDINGS INC. revenues for the quarter ending 2017-12-31 was $2.58B, a 10.22% increase year-over-year.
- IQVIA HOLDINGS INC. revenues for the quarter ending 2017-09-30 was $2.46B, a 64.66% increase year-over-year.
- IQVIA HOLDINGS INC. revenues for the quarter ending 2017-06-30 was $2.38B, a 52.93% increase year-over-year.
- IQVIA HOLDINGS INC. revenues for the quarter ending 2017-03-31 was $2.32B, a 55.84% increase year-over-year.
- IQVIA HOLDINGS INC. revenues for fiscal 2017 was $9.74B, a 41.60% increase from fiscal 2016.
- IQVIA HOLDINGS INC. revenues for fiscal 2016 was $6.88B, a 19.89% increase from fiscal 2015.
- IQVIA HOLDINGS INC. revenues for fiscal 2015 was $5.74B, a 5.07% increase from fiscal 2014.
- IQVIA HOLDINGS INC. revenues for fiscal 2014 was $5.46B, a 7.07% increase from fiscal 2013.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $2.58B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $5.04B derived: sum of 2 quarters · filed 2018-02-16 | $7.42B derived: sum of 3 quarters · filed 2018-02-16 | $9.74B 10-K · filed 2018-02-16 | ||||
| 2017-09-30 | $2.46B 10-Q · filed 2017-10-27 | $4.84B derived: sum of 2 quarters · filed 2017-10-27 | $7.16B 10-Q · filed 2017-10-27 | $9.50B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2017-06-30 | $2.38B 10-Q · filed 2017-08-04 | $4.70B 10-Q · filed 2017-08-04 | $7.04B derived: sum of 3 quarters · filed 2018-02-16 | $8.53B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2017-03-31 | $2.32B 10-Q · filed 2017-05-08 | $4.66B derived: sum of 2 quarters · filed 2018-02-16 | $6.16B derived: sum of 3 quarters · filed 2018-02-16 | $7.71B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-12-31 | $2.34B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $3.83B derived: sum of 2 quarters · filed 2018-02-16 | $5.39B derived: sum of 3 quarters · filed 2018-02-16 | $6.88B 10-K · filed 2018-02-16 | ||||
| 2016-09-30 | $1.50B 10-Q · filed 2017-10-27 | $1.50B 10-Q · filed 2016-11-03 | $3.05B derived: sum of 2 quarters · filed 2017-10-27 | $4.54B 10-Q · filed 2017-10-27 | $4.54B 10-Q · filed 2016-11-03 | $6.06B derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-06-30 | $1.55B 10-Q · filed 2017-08-04 | $1.55B 10-Q · filed 2016-07-27 | $3.04B 10-Q · filed 2017-08-04 | $3.04B 10-Q · filed 2016-07-27 | $4.56B derived: sum of 3 quarters · filed 2018-02-16 | $5.99B derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-03-31 | $1.49B 10-Q · filed 2017-05-08 | $1.49B 10-Q · filed 2016-05-03 | $3.01B derived: sum of 2 quarters · filed 2018-02-16 | $4.44B derived: sum of 3 quarters · filed 2018-02-16 | $5.88B derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | $1.52B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $2.95B derived: sum of 2 quarters · filed 2018-02-16 | $4.39B derived: sum of 3 quarters · filed 2018-02-16 | $5.74B 10-K · filed 2018-02-16 | $5.74B 10-K · filed 2016-02-11 | |||
| 2015-09-30 | $1.42B 10-Q · filed 2016-11-03 | $2.87B derived: sum of 2 quarters · filed 2016-11-03 | $4.22B 10-Q · filed 2016-11-03 | $5.63B derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | $1.44B 10-Q · filed 2016-07-27 | $2.79B 10-Q · filed 2016-07-27 | $4.20B derived: sum of 3 quarters · filed 2017-02-16 | $5.60B derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | $1.35B 10-Q · filed 2016-05-03 | $2.76B derived: sum of 2 quarters · filed 2017-02-16 | $4.16B derived: sum of 3 quarters · filed 2017-02-16 | $5.50B derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2014-12-31 | $1.41B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $2.81B derived: sum of 2 quarters · filed 2017-02-16 | $4.15B derived: sum of 3 quarters · filed 2017-02-16 | $5.46B 10-K · filed 2017-02-16 | $5.46B 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $1.40B 10-Q · filed 2015-10-28 | $2.74B derived: sum of 2 quarters · filed 2015-10-28 | $4.05B 10-Q · filed 2015-10-28 | $5.43B derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-06-30 | $1.34B 10-Q · filed 2015-07-29 | $2.65B 10-Q · filed 2015-07-29 | $4.03B derived: sum of 3 quarters · filed 2016-02-11 | $5.22B derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | $1.31B 10-Q · filed 2015-04-29 | $2.69B derived: sum of 2 quarters · filed 2016-02-11 | $3.88B derived: sum of 3 quarters · filed 2016-02-11 | $5.18B derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | $1.38B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $2.58B derived: sum of 2 quarters · filed 2016-02-11 | $3.87B derived: sum of 3 quarters · filed 2016-02-11 | $5.10B 10-K · filed 2016-02-11 | ||||
| 2013-09-30 | $1.20B 10-Q · filed 2014-10-30 | $2.49B derived: sum of 2 quarters · filed 2014-10-30 | $3.72B 10-Q · filed 2014-10-30 | $5.00B derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | $1.30B 10-Q · filed 2014-07-31 | $2.52B 10-Q · filed 2014-07-31 | $3.80B derived: sum of 3 quarters · filed 2015-02-12 | $5.00B derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | $1.23B 10-Q · filed 2014-05-01 | $2.51B derived: sum of 2 quarters · filed 2015-02-12 | $3.71B derived: sum of 3 quarters · filed 2015-02-12 | $4.94B derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | $1.28B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $2.48B derived: sum of 2 quarters · filed 2015-02-12 | $3.71B derived: sum of 3 quarters · filed 2015-02-12 | $4.87B 10-K · filed 2015-02-12 | ||||
| 2012-09-30 | $1.20B 10-Q · filed 2013-10-31 | $2.43B derived: sum of 2 quarters · filed 2013-10-31 | $3.59B 10-Q · filed 2013-10-31 | |||||
| 2012-06-30 | $1.23B 10-Q · filed 2013-08-01 | $2.39B 10-Q · filed 2013-08-01 | ||||||
| 2012-03-31 | $1.16B 10-Q · filed 2013-05-14 | |||||||
| 2011-12-31 | $4.33B 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |